The Congress is focused on “Patient happiness: the Holy Grail of organ substitution” and aims

• to discuss the importance of technical, psychological and ethical issue to patient happiness with serious tissue or organ deficits.
• to re-define the strategy to design and operate devices and treatments to ensure patient happiness. 
• to bring together scientists with medical and technical backgrounds working on development, optimization and translation to clinics of treatments of organ deficits based on artificial, bioartificial, and cell-based organs or prostheses .
• to bridge communication gaps and promote new, or reinforce existing, multidisciplinary collaborations to exploit possible synergies
• to provide up-to-date information on frontier technology to treat serious tissue or organ deficits. 
• to pave the ground for the development of innovative treatments based on artificial, bioartificial and cell-based organs, prostheses or treatments which should ensure happiness, or at least improve on the quality of life, of patients with serious tissue or organ deficits.